ArticleMolecular cancer therapeutics2023

Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo.

Barbara Jonchere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.